Fyn gene silencing reduces oligodendrocytes apoptosis through inhibiting ERK1/2 phosphorylation in epilepsy

References

• Devinsky O, Marsh E, Friedman D. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15(3):270–278.
   PubMed Web of Science ®Google Scholar
• Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus . Am J Hum Genet.. 2001;68(4):859–865.
   PubMed Web of Science ®Google Scholar
• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530.
   PubMed Web of Science ®Google Scholar
• Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol.. 2014;71(3):276–283.
   PubMed Web of Science ®Google Scholar
• Dai AI, Akcali A, Koska S, et al. Contribution of KCNJ10 gene polymorphisms in childhood epilepsy. J Child Neurol.. 2015;30(3):296–300.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Fujiwara H, Kaneko K, et al. Short- and long-term functional plasticity of white matter induced by oligodendrocyte depolarization in the hippocampus. Glia. 2014;62(8):1299–1312.
   PubMed Web of Science ®Google Scholar
• Sanz-Blasco S, Bordone MP, Damianich A, et al. The kinase Fyn as a novel intermediate in l -DOPA-induced dyskinesia in Parkinson’s disease. Mol Neurobiol. 2018;55(6):5125–5136.
   PubMed Web of Science ®Google Scholar
• Huang Y, Li G, An L, et al. Fyn regulates multipolar-bipolar transition and neurite morphogenesis of migrating neurons in the developing neocortex. Neuroscience. 2017;352:39–51.
   PubMed Web of Science ®Google Scholar
• Smith LM, Zhu R, Strittmatter SM. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer’s model. Neuropharmacology. 2018;130:54.
   PubMed Web of Science ®Google Scholar
• Dallari S, Macal M, Loureiro ME, et al. Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses. Nat Commun. 2017;8(1):14830.
   PubMed Web of Science ®Google Scholar
• Szaflarski JP, Devinsky O. Cannabinoids and epilepsy – introduction. Epilepsy Behav. 2017;70(Pt B):277.
   PubMed Web of Science ®Google Scholar
• Sinha N, Dauwels J, Kaiser M, et al. Predicting neurosurgical outcomes in focal epilepsy patients using computational modeling. Brain. 2017;140(2):319–332.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang JY, Gu R, et al. The relationship between the occurrence of intractable epilepsy with glial cells and myelin sheath-an experimental study. Eur Rev Med Pharmacol Sci. 2016;20(21):4516–4524.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Roy NS, Keyoung HM, et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nature Med. 2003;9:439–447.
   Google Scholar
• Xie D, Shen F, He S, et al. IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats. Glia. 2016;64(4):583–602.
   PubMed Web of Science ®Google Scholar
• Lyu S, Han D, Li X, et al. Fyn knockdown inhibits migration and invasion in cholangiocarcinoma through the activated AMPK/mTOR signaling pathway. Oncol Lett. 2018;15:2085–2090.
   PubMed Web of Science ®Google Scholar
• Thompson SJ, Ashley MD, Stöhr S, et al. Suppression of TNF receptor-1 signaling in an in vitro model of epileptic tolerance. Int J Physiol Pathophysiol Pharmacol. 2011;3:120–132.
   PubMedGoogle Scholar
• Huang LG, Zou J, Lu QC. Silencing rno-miR-155-5p in rat temporal lobe epilepsy model reduces pathophysiological features and cell apoptosis by activating Sestrin-3. Brain Res. 2018;1689:109.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang J, Wang W, et al. Effect of lamotrigine on epilepsy-induced cognitive impairment and hippocampal neuronal apoptosis in pentylenetetrazole-kindled animal model. Synapse. 2017;71(2):e21945.
   Web of Science ®Google Scholar
• Ge LC, Wang HS. A commentary on “Involvement of activating ERK1/2 trough G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells”. Toxicol Lett. 2016;240(1):236–237.
   PubMed Web of Science ®Google Scholar
• Chen M, Dai LH, Fei A, et al. Isoquercetin activates the ERK1/2-Nrf2 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Experiment Therapeutic Med. 2017;13:1353.
   PubMed Web of Science ®Google Scholar
• Bhowmick S, D’Mello V, Abdul-Muneer PM. Synergistic inhibition of ERK1/2 and JNK, not p38, phosphorylation ameliorates neuronal damages after traumatic brain injury. Mol Neurobiol. 2019;56(2):1124–1136.
   PubMed Web of Science ®Google Scholar
• Pilar NM, Elisabet GP, Olmo Marisol MD. Compound inhibiting activation of the enzyme ERK1/2 for use in the treatment of neurogenerative illnesses. WO2011147999. 2016.
   Google Scholar
• Hu SP, Zhao JJ, Wang WX, et al. Dexmedetomidine increases acetylation level of histone through ERK1/2 pathway in dopamine neuron. Hum Exp Toxicol. 2017;36:474–482.
   PubMed Web of Science ®Google Scholar